Volume | 14,456 |
|
|||||
Noticias | - | ||||||
Máximo del Dia | 3.20 | Mínimo Máximo |
|||||
Minimo del Dia | 3.01 |
Nombre de la Acción | Símbolo de la Acción | Bolsa de Valores | Tipo de Valor |
---|---|---|---|
MEI Pharma Inc | MEIP | NASDAQ | Acción Común |
Precio de Apertura | Precio Mínimo | Precio Máximo | Precio de cierre | Precio Anterior |
---|---|---|---|---|
3.01 | 3.01 | 3.20 | 3.06 | 3.05 |
Operaciones | Volume Operado de la Acción | Precio Promedio Ponderado | Volume Financiero | Volumen promedio | Rango 52 semanas |
---|---|---|---|---|---|
145 | 14,456 | US$ 3.11 | US$ 44,930 | - | 3.01 - 7.97 |
Último Operado | Tipo de Operación | Cantidad Operada | Precio Operado | Divisa |
---|---|---|---|---|
16:57:57 | 1 | US$ 3.06 | USD |
Información Financiera MEI Pharma Inc MEIP
Capitalización de Mercado [m] | Acciones en circulación | Float | Ingresos | Ganancia/Pérdida | Utilidad por Acción (UPA) | Ratio Precio/Utilidad |
---|---|---|---|---|---|---|
20.45M | 6.66M | - | 48.82M | -31.84M | -4.78 | - |
Interés de corto | Dividendos Por Acción | Rendimiento del Dividendo | Fecha esperada de dividendos | Transacciones ejecutivas | % de acciones controladas por todos los ejecutivos y 5% propietarios: |
---|---|---|---|---|---|
- | - | - | - |
Noticias sobre MEI Pharma Inc MEIP
Fecha | Hora | Fuente | Noticias Artículo |
---|---|---|---|
11/4/2024 | 07:02 | Business Wire | MEI Pharma Board of Directors Aligns on Strategy to Advance.. |
11/4/2024 | 07:00 | Business Wire | MEI Pharma Reports Initial Data from Clinical Study.. |
10/4/2024 | 07:00 | Business Wire | MEI Pharma to Present at the Stifel 2024 Virtual Targeted.. |
26/3/2024 | 07:00 | Business Wire | MEI Pharma Reports Update from Clinical Study Evaluating.. |
28/2/2024 | 23:15 | Edgar (US Regulatory) | Form EFFECT - Notice of Effectiveness |
21/2/2024 | 15:00 | Edgar (US Regulatory) | Form 8-K - Current report |
20/2/2024 | 16:33 | Edgar (US Regulatory) | Form S-3 - Registration statement under Securities Act of.. |
13/2/2024 | 16:05 | Edgar (US Regulatory) | Form 8-K - Current report |
13/2/2024 | 16:05 | Business Wire | MEI Pharma Reports Second Quarter Fiscal Year 2024 Results.. |
17/1/2024 | 15:00 | Edgar (US Regulatory) | Form 8-K - Current report |
16/1/2024 | 16:00 | Business Wire | MEI Pharma to Present Design of Ongoing Clinical Study.. |
26/12/2023 | 16:00 | Edgar (US Regulatory) | Form 8-K - Current report |
Histórico de Datos MEIP
Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 3.38 | 3.45 | 3.01 | 3.11 | 8,599 | -0.32 | -9.47% |
1 Month | 4.02 | 4.0651 | 3.01 | 3.49 | 14,065 | -0.96 | -23.88% |
3 Months | 4.69 | 4.97 | 3.01 | 3.94 | 20,838 | -1.63 | -34.75% |
6 Months | 6.88 | 7.8734 | 3.01 | 5.68 | 35,603 | -3.82 | -55.52% |
1 Year | 5.11 | 7.97 | 3.01 | 6.38 | 43,384 | -2.05 | -40.12% |
3 Years | 72.00 | 73.20 | 3.01 | 19.37 | 1,267,300 | -68.94 | -95.75% |
5 Years | 63.60 | 91.50 | 3.01 | 31.85 | 1,112,523 | -60.54 | -95.19% |